We’re launching a new capital increase for 2022

We aim to finance Phase III clinical trials for brain tumor treatment.

For more information about this investment opportunity,

visit Crowdfunding for Laminar Pharma at Capital Cell or

email inversores@laminarpharma.com.

Company News

Scientific publications